This represents a dramatic jump from 79 million measures taken in May as the government tries to reverse the vaccine deficit.
India will receive about 120 million home-grown coronavirus vaccines in June, the government said Sunday, bolstering its vaccination campaign hampered by a lack of jabs.
This represents the biggest jump from the 79.4 million figures found in May during the second devastating wave that has killed more than 150,000 people in the past eight weeks.
India has provided about 212 million medicines, more after China and the United States, but has provided the necessary two-thirds of the 1.35 billion people.
The world’s second-largest country on Sunday reported a daily decline in new coronavirus infections in 46 days in 165,553 cases in the last 24 hours, with 3,460 deaths.
The prevalence of the disease in South Asia is now at 27.9 million, with the death toll rising to 325,972, Health Ministry data showed on Sunday.
Earlier this month, a senior government adviser said more than two billion antiretroviral drugs could be available in India between August and December this year, including those from home.
Several Indian states say the vaccine is in short supply, forcing many areas, including the capital of New Delhi, to prioritize those over the age of 45.
In June, 60.9 million units will be provided by the government to eliminate medical and facial vaccines for those over the age of 45, while 58.6 million units will be available for direct purchase by international private hospitals, the release said.
The country has begun producing the Russian Sputnik V vaccine, along with the local AstraZeneca vaccine made at the Serum Institute of India (SII) and Covaxin by the local company Bharat Biotech.
The world has been plagued by vaccinations despite the world’s largest vaccineers.
Opponents say Prime Minister Narendra Modi says he is responding to his response to COVID-19, due to a shortage of medical beds, air, vaccines and medicines available to heads around the world.